Provider

HIMSS senior market insights manager Nicole Ramage discusses new research that explores what executive and IT leaders are saying about the challenges and benefits of using artificial intelligence.

Also, a startup in India has received seed funding to expand further its VR-based mental health DTx.

The partners will work to bring AI-powered motion-capture technology to the physical therapy market in order to reduce administrative workloads.

The collaboration will integrate NeuroFlow's workflow tools into the medical center's ambulatory care settings.  

Rob Havasy, senior director of the thought advisory group at HIMSS, relays how AI technology is maturing, including people's understanding of the technology and the processes organizations are putting in place to overcome past shortcomings.

Highmark members with low back pain can now get a prescription for the VR company's FDA-cleared RelieVRx.  

The pharma giant will integrate more than 20 AI algorithms from eight collaborators into its navify Digital Pathology enterprise software to help improve pathology workflows.  

Dr. Eve Cunningham, chief of virtual care and digital health at Providence, discusses clinician response to AI, promoting education and engagement within the healthcare workforce and how AI can help providers stay current on patient care.

AlphaProteo was created to advance drug design and disease understanding by helping researchers configure high-strength proteins that bind to molecules.

The company will use the funds to launch its diagnostics division and expand its offerings under the helm of its new chief operating officer.